Adam Maeder
Stock Analyst at Piper Sandler
(3.96)
# 689
Out of 4,502 analysts
88
Total ratings
55%
Success rate
9.42%
Average return
Main Sectors:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Overweight | $490 → $495 | $454.02 | +9.03% | 13 | Jul 19, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $16.48 | +27.43% | 2 | May 22, 2024 | |
| NVRO Nevro | Maintains: Underweight | $15 → $12 | $9.74 | +23.20% | 12 | May 8, 2024 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $250 → $255 | $139.60 | +82.66% | 11 | May 8, 2024 | |
| SILK Silk Road Medical | Maintains: Neutral | $18 → $20 | $27.08 | -26.14% | 6 | May 1, 2024 | |
| NARI Inari Medical | Maintains: Neutral | $55 → $50 | $55.39 | -9.73% | 4 | May 1, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $85 → $88 | $86.95 | +1.21% | 10 | Apr 26, 2024 | |
| STIM Neuronetics | Reiterates: Overweight | $7 → $8 | $1.88 | +325.53% | 1 | Mar 6, 2024 | |
| NYXH Nyxoah | Maintains: Overweight | $15 → $20 | $8.18 | +144.50% | 8 | Mar 6, 2024 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $45 → $30 | $7.45 | +302.68% | 4 | Mar 5, 2024 | |
| AXNX Axonics | Downgrades: Neutral | $75 → $71 | $68.01 | +4.40% | 6 | Jan 12, 2024 | |
| NSPR InspireMD | Maintains: Overweight | $3.5 → $4.5 | $2.93 | +53.58% | 2 | Nov 2, 2023 | |
| TCMD Tactile Systems Technology | Maintains: Overweight | $25 → $30 | $12.88 | +132.92% | 2 | May 9, 2023 | |
| STXS Stereotaxis | Maintains: Overweight | $6 → $5 | $1.99 | +151.26% | 2 | Mar 6, 2023 | |
| ZYXI Zynex | Upgrades: Overweight | $10 → $18 | $10.08 | +78.57% | 2 | Jan 6, 2023 | |
| LIVN LivaNova | Maintains: Overweight | $104 → $99 | $53.77 | +84.12% | 3 | May 5, 2022 |
Intuitive Surgical
Jul 19, 2024
Maintains: Overweight
Price Target: $490 → $495
Current: $454.02
Upside: +9.03%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $16.48
Upside: +27.43%
Nevro
May 8, 2024
Maintains: Underweight
Price Target: $15 → $12
Current: $9.74
Upside: +23.20%
Inspire Medical Systems
May 8, 2024
Maintains: Overweight
Price Target: $250 → $255
Current: $139.60
Upside: +82.66%
Silk Road Medical
May 1, 2024
Maintains: Neutral
Price Target: $18 → $20
Current: $27.08
Upside: -26.14%
Inari Medical
May 1, 2024
Maintains: Neutral
Price Target: $55 → $50
Current: $55.39
Upside: -9.73%
Edwards Lifesciences
Apr 26, 2024
Maintains: Neutral
Price Target: $85 → $88
Current: $86.95
Upside: +1.21%
Neuronetics
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.88
Upside: +325.53%
Nyxoah
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $8.18
Upside: +144.50%
Vicarious Surgical
Mar 5, 2024
Maintains: Neutral
Price Target: $45 → $30
Current: $7.45
Upside: +302.68%
Axonics
Jan 12, 2024
Downgrades: Neutral
Price Target: $75 → $71
Current: $68.01
Upside: +4.40%
InspireMD
Nov 2, 2023
Maintains: Overweight
Price Target: $3.5 → $4.5
Current: $2.93
Upside: +53.58%
Tactile Systems Technology
May 9, 2023
Maintains: Overweight
Price Target: $25 → $30
Current: $12.88
Upside: +132.92%
Stereotaxis
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $1.99
Upside: +151.26%
Zynex
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $10.08
Upside: +78.57%
LivaNova
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $53.77
Upside: +84.12%